FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
08/07/2023
Back to search
Official data from USPTO
LIBER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
08/07/2023
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
10/27/2021
Registration date
03/28/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/28/2023
Last transaction
03/28/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
82
Owner location
AU
Examiner
NEAL, KELLY
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the literal element "LIBER" within a shaded rectangle with rounded edges on the upper left and bottom right corners.
Holders and representatives
Holders
LIBER PHARMACEUTICALS PTY LTD
Representatives
Jennifer A. Visintine Thompson Coburn LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Chemical preparations for pharmaceutical purposesfor the treatment of smoking and nicotine cessation; chemical preparations consisting of mixed or unmixed restricted substances being nicotine for curative purposesincluding medicaltherapeuticprophylacticpharmaceutical uses contained within a containera cartridge in a measured dose for the treatment of smoking and nicotine cessation; chemical preparations consisting of mixed or unmixed restricted substances being nicotine for medical useincluding therapeuticprophylacticpharmaceutical use contained within a containera cartridge in a measured dose for the treatment of smoking and nicotine cessation; chemical preparations consisting of mixed or unmixed restricted substances being nicotine for pharmaceutical useincluding therapeutic or prophylactic use contained within a containera cartridge in a measured dosefor the treatment of smoking and nicotine cessation; chemicals for pharmaceutical usefor the treatment of smoking and nicotine cessation; dietetic preparations adapted for medical use; dietetic preparations adapted for medical usedietary supplements for the treatment of smoking and nicotine cessation; drugs for medical purposesfor the treatment of smoking and nicotine cessation; imitation cigarettes for quitting smoking; medical preparations for the treatment of smoking and nicotine cessation; medicaments in liquid form for the treatment of smoking and nicotine cessation; medicated preparations for the treatment of smoking and nicotine cessation; medicament preparations for use as anti-smoking devices; pharmaceutical compositions for the treatment of smoking and nicotine cessation; pharmaceutical drugs for the treatment of smoking and nicotine cessation; pharmaceutical preparations for the treatment of smoking and nicotine cessation; pharmaceutical preparations for health carefor the treatment of smoking and nicotine cessation; pharmaceutical preparations for use in discouraging the smoking habit; pharmaceutical products for the treatment of smoking and nicotine cessation; pharmaceutical substances for the treatment of smoking and nicotine cessation; tobacco substitutes for medical purposesfor the treatment of smoking and nicotine cessation; tobacco-free cigarettes for smoking cessation purposes
Publications
History of USPTO decisions and trademark events.
30 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/19/2023
FIMP
FINAL DISPOSITION PROCESSED
07/19/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/28/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/28/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
03/28/2023
ATRV
ATTORNEY REVIEW COMPLETED
02/07/2023
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
02/06/2023
GPNX
NOTIFICATION PROCESSED BY IB
01/25/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/10/2023
PUBO
PUBLISHED FOR OPPOSITION
01/10/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/04/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/21/2022
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
12/20/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/02/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/29/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/28/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/28/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/17/2022
RFNT
REFUSAL PROCESSED BY IB
06/22/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/28/2022
RFRR
REFUSAL PROCESSED BY MPU
05/28/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/26/2022
CNRT
NON-FINAL ACTION WRITTEN
04/25/2022
DOCK
ASSIGNED TO EXAMINER
04/11/2022
MAFR
APPLICATION FILING RECEIPT MAILED
03/29/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/24/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
03/23/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/17/2022
Continuous trademark protection
Get notified about every new filing that threatens LIBER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.